Evelo Biosciences Pink Sheet Forecast - Naive Prediction
| EVLO Stock | USD 0.0002 0.0003 60.00% |
The Naive Prediction forecasted value of Evelo Biosciences on the next trading day is expected to be -0 with a mean absolute deviation of 0.000074 and the sum of the absolute errors of 0. Evelo Pink Sheet Forecast is based on your current time horizon.
As of today the relative strength index (rsi) of Evelo Biosciences' share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Evelo Biosciences hype-based prediction, you can estimate the value of Evelo Biosciences from the perspective of Evelo Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Evelo Biosciences on the next trading day is expected to be -0 with a mean absolute deviation of 0.000074 and the sum of the absolute errors of 0. Evelo Biosciences after-hype prediction price | USD 1.59E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Evelo |
Evelo Biosciences Additional Predictive Modules
Most predictive techniques to examine Evelo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Evelo using various technical indicators. When you analyze Evelo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Evelo Biosciences Naive Prediction Price Forecast For the 24th of January
Given 90 days horizon, the Naive Prediction forecasted value of Evelo Biosciences on the next trading day is expected to be -0 with a mean absolute deviation of 0.000074, mean absolute percentage error of 0.00000001, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Evelo Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Evelo Biosciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Evelo Biosciences Pink Sheet Forecast Pattern
| Backtest Evelo Biosciences | Evelo Biosciences Price Prediction | Buy or Sell Advice |
Evelo Biosciences Forecasted Value
In the context of forecasting Evelo Biosciences' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Evelo Biosciences' downside and upside margins for the forecasting period are 0.000002 and 53.20, respectively. We have considered Evelo Biosciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Evelo Biosciences pink sheet data series using in forecasting. Note that when a statistical model is used to represent Evelo Biosciences pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 101.4084 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.0E-4 |
| MAPE | Mean absolute percentage error | 0.2957 |
| SAE | Sum of the absolute errors | 0.0046 |
Predictive Modules for Evelo Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Evelo Biosciences. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Evelo Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Evelo Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Evelo Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Evelo Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Evelo Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Evelo Biosciences' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Evelo Biosciences' historical news coverage. Evelo Biosciences' after-hype downside and upside margins for the prediction period are 0.00 and 50.01, respectively. We have considered Evelo Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Evelo Biosciences is out of control at this time. Analysis and calculation of next after-hype price of Evelo Biosciences is based on 3 months time horizon.
Evelo Biosciences Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Evelo Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Evelo Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Evelo Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
3.85 | 53.20 | 0.00 | 0.00 | 0 Events / Month | 2 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0002 | 0.0002 | 20.62 |
|
Evelo Biosciences Hype Timeline
Evelo Biosciences is currently traded for 0.0002. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Evelo is expected to decline in value after the next headline, with the price expected to drop to 1.59E-4. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -20.62%, whereas the daily expected return is currently at 3.85%. The volatility of related hype on Evelo Biosciences is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 83.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 15.64. Evelo Biosciences had not issued any dividends in recent years. The entity had 1:20 split on the 30th of June 2023. Given the investment horizon of 90 days the next expected press release will be in a few days. Check out Historical Fundamental Analysis of Evelo Biosciences to cross-verify your projections.Evelo Biosciences Related Hype Analysis
Having access to credible news sources related to Evelo Biosciences' direct competition is more important than ever and may enhance your ability to predict Evelo Biosciences' future price movements. Getting to know how Evelo Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Evelo Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| INFIQ | Infinity Pharmaceuticals | 0.00 | 8 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LIFS | Life Stem Genetics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ARDS | Aridis Pharmaceuticals | 0.00 | 0 per month | 37.33 | 0.34 | 1,000.00 | (90.48) | 1,141 | |
| STAB | Statera Biopharma | 0.00 | 0 per month | 21.51 | 0.19 | 100.00 | (66.67) | 275.00 | |
| TRVN | Trevena | 0.00 | 6 per month | 0.00 | 0.11 | 0.00 | 0.00 | 1,000.00 | |
| ICCT | iCoreConnect Common stock | 0.00 | 0 per month | 31.71 | 0.16 | 100.00 | (72.73) | 522.73 | |
| HSTC | HST Global | 0.00 | 0 per month | 0.00 | 0.18 | 0.00 | 0.00 | 4,954 | |
| PXMD | PaxMedica Common Stock | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 4,998 | |
| BTAX | Biostax Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SECI | Sector 10 | 0.00 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for Evelo Biosciences
For every potential investor in Evelo, whether a beginner or expert, Evelo Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Evelo Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Evelo. Basic forecasting techniques help filter out the noise by identifying Evelo Biosciences' price trends.Evelo Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Evelo Biosciences pink sheet to make a market-neutral strategy. Peer analysis of Evelo Biosciences could also be used in its relative valuation, which is a method of valuing Evelo Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Evelo Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Evelo Biosciences pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Evelo Biosciences shares will generate the highest return on investment. By undertsting and applying Evelo Biosciences pink sheet market strength indicators, traders can identify Evelo Biosciences entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.4 | |||
| Day Median Price | 2.0E-4 | |||
| Day Typical Price | 2.0E-4 | |||
| Price Action Indicator | (0.0001) | |||
| Period Momentum Indicator | (0.0003) |
Evelo Biosciences Risk Indicators
The analysis of Evelo Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Evelo Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting evelo pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 16.89 | |||
| Standard Deviation | 54.2 | |||
| Variance | 2938.14 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Evelo Biosciences
The number of cover stories for Evelo Biosciences depends on current market conditions and Evelo Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Evelo Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Evelo Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Evelo Biosciences Short Properties
Evelo Biosciences' future price predictability will typically decrease when Evelo Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Evelo Biosciences often depends not only on the future outlook of the potential Evelo Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Evelo Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.4 M | |
| Cash And Short Term Investments | 47.9 M |
Other Information on Investing in Evelo Pink Sheet
Evelo Biosciences financial ratios help investors to determine whether Evelo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Evelo with respect to the benefits of owning Evelo Biosciences security.